Johnson & Johnson (JNJ)
238.46
-2.85
(-1.18%)
USD |
NYSE |
Apr 10, 16:00
238.76
+0.30
(+0.13%)
After-Hours: 20:00
Johnson & Johnson Free Cash Flow : 19.70B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 9.456B |
| Protagonist Therapeutics, Inc. | 56.08M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.309B |
| Cash from Investing (Quarterly) | -4.485B |
| Cash from Financing (Quarterly) | -1.369B |
| Free Cash Flow Per Share (Quarterly) | 2.401 |
| Free Cash Flow to Equity (Quarterly) | 2.319B |
| Free Cash Flow to Firm (Quarterly) | 6.362B |
| Free Cash Flow Yield | 3.40% |